ArticleIntroducing Bio-Map Europe: the strategic market access plan ‘in a box’ for Biotech
If you are an innovative, SME Biotech company, in the clinic, with a potential approval in the next 3-4 years, but concerned about the evidence you will need to achieve successful pricing and reimbursement in the highly complex European markets, Bio-MAP Europe was designed specifically for you.